[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336300-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336300-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cholinergic-mechanisms-in-gastrointestinal-neoplasia-review","Cholinergic Mechanisms in Gastrointestinal Neoplasia - Review","","Acetylcholine-activated receptors fall into two major structurally distinct groups: ligand-gated ion channel nicotinic receptors and G-protein-coupled muscarinic receptors. Both receptor classes, through constitutive or ligand-induced cholinergic signaling, have been linked to the induction and progression of gastrointestinal neoplasia. The review summarizes receptor classification, normal digestive cholinergic function, acetylcholine synthesis/release within the gastrointestinal microenvironment, and current challenges in accurately measuring acetylcholine in serum and tissues, with emphasis on stomach, pancreas, and colon adenocarcinomas.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cholinergic-mechanisms-in-gastrointestinal-neoplasia-review/336300/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cholinergic-mechanisms-in-gastrointestinal-neoplasia-review/336300.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How are cholinergic signaling receptors classified in gastrointestinal neoplasia research?","Question",{"text":63,"@type":64},"Acetylcholine-activated receptors are broadly divided into nicotinic receptors (ligand-gated ion channel) and muscarinic receptors (G-protein-coupled), each with multiple related subtypes and distinct tissue expression and signaling mechanisms.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role does cholinergic signaling play in the development of gastrointestinal tumors?",{"text":68,"@type":64},"The review evaluates evidence that constitutive and ligand-induced activation of acetylcholine-activated receptors promotes gastrointestinal neoplasia, particularly focusing on stomach, pancreas, and colon adenocarcinomas.",{"name":70,"@type":61,"acceptedAnswer":71},"What methodological challenges are discussed for measuring acetylcholine?",{"text":72,"@type":64},"The review considers current methodology and challenges involved in accurately measuring acetylcholine levels in both serum and tissue, as part of linking cholinergic activity to tumor biology.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336300,1790177906,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":99,"preview_page_count":33,"preview_urls":145},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Review  \nCholinergic Mechanisms in Gastrointestinal Neoplasia  \nNatalia Sampaio Moura 1,†, Alyssa Schledwitz 1,†, Madeline Alizadeh 2, Asha Kodan 1, Lea-Pearl Njei 3 and Jean-Pierre Raufman 1,4,5,6, *  \nCitation: Sampaio Moura, N.; Schledwitz, A.; Alizadeh, M.; Kodan, A.; Njei, L.-P.; Raufman, J.-P. Cholinergic Mechanisms in Gastrointestinal Neoplasia. Int. J. Mol. Sci. 2024, 25, 5316. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms25105316](10.3390/ijms25105316)  \nAcademic Editor: Antonio Pisani  \nReceived: 29 March 2024  \nRevised: 9 May 2024  \nAccepted: 11 May 2024  \nPublished: 13 May 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Medicine, Division of Gastroenterology and Hepatology, University of Maryland School of Medicine, Baltimore, MD 21201, USA; [natalia.sampaiomoura@som.umaryland.edu](natalia.sampaiomoura@som.umaryland.edu) (N.S.M.); [alyssa.schledwitz@som.umaryland.edu](alyssa.schledwitz@som.umaryland.edu) (A.S.); [akodan@som.umaryland.edu](akodan@som.umaryland.edu) (A.K.)  \n2 The Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD 21201, USA; [madeline.alizadeh@som.umaryland.edu](madeline.alizadeh@som.umaryland.edu)  \n3 Department of Biological Science, University of Maryland, Baltimore County, Baltimore, MD 21250, USA; [lnjei1@umbc.edu](lnjei1@umbc.edu)  \n4 Veterans Affairs Maryland Healthcare System, Baltimore, MD 21201, USA  \n5 Marlene and Stewart Greenebaum Cancer Center, University of Maryland Medical Center, Baltimore, MD 21201, USA  \n6 Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201, USA  \n* [Correspondence: jraufman@som.umaryland.edu](Correspondence: jraufman@som.umaryland.edu); Tel.: +410-328-8728 † These authors contributed equally to this work.  \nAbstract: Acetylcholine-activated receptors are divided broadly into two major structurally distinct classes: ligand-gated ion channel nicotinic and G-protein-coupled muscarinic receptors. Each class encompasses several structurally related receptor subtypes with distinct patterns of tissue expression and post-receptor signal transduction mechanisms. The activation of both nicotinic and muscariniccholinergic receptors has been associated with the induction and progression of gastrointestinal neoplasia. Herein, after briefly reviewing the classification of acetylcholine-activated receptors and the role that nicotinic and muscarinic cholinergic signaling plays in normal digestive function, we consider the mechanics of acetylcholine synthesis and release by neuronal and non-neuronal cells in the gastrointestinal microenvironment, and current methodology and challenges in measuring serum and tissue acetylcholine levels accurately. Then, we critically evaluate the evidence that constitutive and ligand-induced activation of acetylcholine-activated receptors plays a role in promoting gastrointestinal neoplasia. We focus primarily on adenocarcinomas of the stomach, pancreas, and colon, because these cancers are particularly common worldwide and, when diagnosed at an advanced stage, are associated with very high rates of morbidity and mortality. Throughout this comprehensive review, we concentrate on identifying novel ways to leverage these observations for prognostic and therapeutic purposes.  \nKeywords: acetylcholine; gastrointestinal cancer; cancer; brain–gut axis; muscarinic receptors; nicotinic receptors; cellular signaling; protein kinases  \n1. Introduction  \nElegant pharmacological studies conducted by the esteemed British physiologist Sir Henry Dale exploring the differential actions of two naturally occurring a","cbCaieVv0c07s7es","https://ap.wps.com/l/cbCaieVv0c07s7es","pdf",1999375,24,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"How are cholinergic signaling receptors classified in gastrointestinal neoplasia research?\",\"answer\":\"Acetylcholine-activated receptors are broadly divided into nicotinic receptors (ligand-gated ion channel) and muscarinic receptors (G-protein-coupled), each with multiple related subtypes and distinct tissue expression and signaling mechanisms.\"},{\"question\":\"What role does cholinergic signaling play in the development of gastrointestinal tumors?\",\"answer\":\"The review evaluates evidence that constitutive and ligand-induced activation of acetylcholine-activated receptors promotes gastrointestinal neoplasia, particularly focusing on stomach, pancreas, and colon adenocarcinomas.\"},{\"question\":\"What methodological challenges are discussed for measuring acetylcholine?\",\"answer\":\"The review considers current methodology and challenges involved in accurately measuring acetylcholine levels in both serum and tissue, as part of linking cholinergic activity to tumor biology.\"}]","Cholinergic Mechanisms in Gastrointestinal Neoplasia - Review | PDF",1790014469,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12ac7785b19831c3725f5d147b0025df.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c1ac4a4c5910e83286f43961b54b310.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff415e8cf24be9cfaadfa42b7b749c50.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96d9a5861aef0ba029f9dd44b0e91a12.webp",980,1385]